BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11444386)

  • 1. Immune recognition, response, and regulation: how T lymphocytes do it.
    Joyce S
    Immunol Res; 2001; 23(2-3):215-28. PubMed ID: 11444386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
    Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
    Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD1 antigen presentation and infectious disease.
    Dascher CC; Brenner MB
    Contrib Microbiol; 2003; 10():164-82. PubMed ID: 12530326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD1 antigen presentation: how it works.
    Barral DC; Brenner MB
    Nat Rev Immunol; 2007 Dec; 7(12):929-41. PubMed ID: 18037897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD1d-mediated antigen presentation to natural killer T (NKT) cells.
    Brutkiewicz RR; Lin Y; Cho S; Hwang YK; Sriram V; Roberts TJ
    Crit Rev Immunol; 2003; 23(5-6):403-19. PubMed ID: 15030309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse NK1+ T cells.
    Bendelac A
    Curr Opin Immunol; 1995 Jun; 7(3):367-74. PubMed ID: 7546402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential requirement for tapasin in the presentation of leader- and insulin-derived peptide antigens to Qa-1b-restricted CTLs.
    Li L; Sullivan BA; Aldrich CJ; Soloski MJ; Forman J; Grandea AG; Jensen PE; Van Kaer L
    J Immunol; 2004 Sep; 173(6):3707-15. PubMed ID: 15356116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of immune responses by CD1d-restricted natural killer T cells.
    Van Kaer L
    Immunol Res; 2004; 30(2):139-53. PubMed ID: 15477656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD1 proteins: targets of T cell recognition in innate and adaptive immunity.
    Ulrichs T; Porcelli SA
    Rev Immunogenet; 2000; 2(3):416-32. PubMed ID: 11256748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid and small-molecule display by CD1 and MR1.
    Van Rhijn I; Godfrey DI; Rossjohn J; Moody DB
    Nat Rev Immunol; 2015 Oct; 15(10):643-54. PubMed ID: 26388332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen presentation by CD1 and MHC-encoded class I-like molecules.
    Melián A; Beckman EM; Porcelli SA; Brenner MB
    Curr Opin Immunol; 1996 Feb; 8(1):82-8. PubMed ID: 8729450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of tapasin in MHC class I antigen presentation in vivo.
    Garbi N; Tan P; Momburg F; Hämmerling GJ
    Adv Exp Med Biol; 2001; 495():71-8. PubMed ID: 11774611
    [No Abstract]   [Full Text] [Related]  

  • 13. Recognition of a shared human prostate cancer-associated antigen by nonclassical MHC-restricted CD8+ T cells.
    Housseau F; Bright RK; Simonis T; Nishimura MI; Topalian SL
    J Immunol; 1999 Dec; 163(11):6330-7. PubMed ID: 10570328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.
    Stanic AK; Park JJ; Joyce S
    Immunology; 2003 Jun; 109(2):171-84. PubMed ID: 12757612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
    Sköld M; Faizunnessa NN; Wang CR; Cardell S
    J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and Consequences of Antigen Presentation by CD1.
    Van Kaer L; Wu L; Joyce S
    Trends Immunol; 2016 Nov; 37(11):738-754. PubMed ID: 27623113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
    Stober D; Jomantaite I; Schirmbeck R; Reimann J
    J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove.
    Zeng Z; Castaño AR; Segelke BW; Stura EA; Peterson PA; Wilson IA
    Science; 1997 Jul; 277(5324):339-45. PubMed ID: 9219685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKT cells: T lymphocytes with innate effector functions.
    Van Kaer L
    Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.